Effect of a Lysolecithin Analogue on Nonspecific Resistance to Infection of Mice Free

Abstract

Summary

The effect of racemic 1-octadecyl-2-methoxy-sn-glycero-3 phosphorylcholine (ET-18-OCH) on the nonspecific resistance of mice to infection with was investigated. Two strains with different virulence were studied and no effect was observed in either case at concentrations of ET-18-OCH up to 100 g/mouse. However, a concentration of 500 g/mouse caused decreased resistance to , correlating with a depression of carbon clearance. Treatment of macrophages with ET-18-OCH inhibited phagosome-lysosome fusion, but had no effect on zymosan-induced luminol-dependent chemiluminescence. The relationship between the adjuvant and nonspecific anti-infectious activity of ET-18-OCH and other compounds is discussed.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-19-2-159
1985-04-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/19/2/medmicro-19-2-159.html?itemId=/content/journal/jmm/10.1099/00222615-19-2-159&mimeType=html&fmt=ahah

References

  1. Allen R C, Loose L D. 1976; Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages. Biochemical and Biophysical Research Communications 69:245–252
    [Google Scholar]
  2. Armstrong J A, Hart P D’A. 1971; Response of cultured macrophages to Mycobacterium tuberculosis with observations on fusion of lysosomes with phagosomes. Journal of Experimental Medicine 134:713–740
    [Google Scholar]
  3. Arnold B, Miller J F A P, Weltzien H U. 1979; Lysolecithin analogs as adjuvants in delayed-type hypersensitivity in mice. I. Characterisation of the adjuvant effect. European Journal of Immunology 9:363–366
    [Google Scholar]
  4. Biozzi G, Benacerraf B, Halpern B N. 1953; Quantitative study of the granulopectic activity of the reticuloendothelial system. II. A study of the kinetics of the granulopectic activity of the R.E.S. in relation to the dose of carbon injected. Relationship between the weight of the organs and their activity. British Journal of Experimental Pathology 34:441–457
    [Google Scholar]
  5. Blumenstock E. 1979; Salmonellose der Maus. Untersuchungen zur Rolle von Makrophagen als Effektorzellen. Ph. D. Thesis University of Freiburg;
    [Google Scholar]
  6. Blumenstock E, Jann K. 1981; Natural Resistance of mice to Salmonella typhimurium: Bacterial activity and chemiluminescence response of murine peritoneal macrophages. Journal of General Microbiology 125:173–183
    [Google Scholar]
  7. Diamantstein T, Wagner B, Odenwald M V, Schulz G. 1971; Stimulation of humoral antibody formation by polyanions. IV. The effects of dextran sulfate on the kinetics of secondary immune response in mice. European Journal of Immunology 1:426–429
    [Google Scholar]
  8. Friedman R L, Moon R J. 1977; Hepatic clearance of Salmonella typhimurium in silica-treated mice. Infection and Immunity 16:1005–1012
    [Google Scholar]
  9. Goren M B, Swendsen C L, Henson J. 1980; Factors modifying the fusion of phagosomes and lysosomes: art, fact and artefact. van Furth R. Mononuclear phagocytes: functional aspects Martinus Nijhoff Publishers; The Hague:999–1038
    [Google Scholar]
  10. Hahn H. 1974; Effects of dextran sulfate 500 on cell-mediated resistance to infection with Listeria monocytogenes in mice. Infection and Immunity 10:1105–1109
    [Google Scholar]
  11. Hart P D’A, Young M R. 1975; Interference with normal phagosome-lysosome fusion in macrophages, using ingested yeast cells and suramin. Nature 256:47–49
    [Google Scholar]
  12. Jann K, Westphal O. 1975; Microbial Polysaccharides. Sela M. The Antigens; 31–125
    [Google Scholar]
  13. Modolell M, Andreesen R, Pahlke W, Brugger U, Munder P G. 1979; Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids. Cancer Research 39:4681–4686
    [Google Scholar]
  14. Munder P G, Modolell M, Ferber E, Fischer H. 1970; The relationship between macrophages and adjuvant activity. van Furth R. Mononuclear phagocytes Blackwell Scientific Publications; Oxford:445–460
    [Google Scholar]
  15. Munder P G, Modolell M, Andreesen R, Weltzien H U, Westphal O. 1979; Lysophosphatidyl-choline (lysolecithin) and its synthetic analogs. Immune-modulating and other biological effects. Springer Seminars in Immunopathology 2:187–203
    [Google Scholar]
  16. Munder Paul G, Modolell M, Andreesen R, Berdel W, Pahlke W, Oepke R, Westphal O. 1983; Generation of tumorcidal macrophages and direct selective destruction of tumor cells by membrane active adjuvants. Mirand E A, Hutchinson W B, Mihich E. Biology of cancer. Progress in Clinical and Biological Research 132 part B Alan R. Liss; New York:393–403
    [Google Scholar]
  17. Munder P G, Modolell M, Bausert W, Oettgen H F, Westphal O. 1981; Alkyllysophospholipids in cancer therapy. Hersh E M, Chirigos M A, Mastrangelo M J. Augmenting agents in cancer therapy Progress in Cancer Research and Therapy 16 Raven Press; New York:441–458
    [Google Scholar]
  18. Reed L J, Muench H. 1938; A simple method of estimating fifty per cent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
  19. Schleupner C J, Glasgow L A. 1978; Peritoneal macrophage activation indicated by enhanced chemiluminescence. Infection and Immunity 21:886–895
    [Google Scholar]
  20. Stein Y, Stein O. 1966; Metabolism of labeled lysolecithin, lysophosphatidylethanolamine and lecithin in the rat. Biochimica et Biophysica Acta 116:95–107
    [Google Scholar]
  21. von Jeney N, Günther E, Jann K. 1977; Mitogenic stimulation of murine spleen cells: relation to susceptibility to Salmonella infection. Infection and Immunity 15:26–33
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-19-2-159
Loading
/content/journal/jmm/10.1099/00222615-19-2-159
Loading

Data & Media loading...

Most cited Most Cited RSS feed